
1. The Announcement at a Glance
-
Size: ₹18,000 crore (~$2.04 bn)
-
Route: Tender offer (fixed price)
-
Buyback Price: ₹1,800/share (≈19% premium to pre-announcement close)
-
Equity Reduction: ~2.41% (100 million shares out of ~4.15 billion)
-
EPS Impact: ~+2.5% accretion (theoretical)
-
Timeline: Record date & tendering window to be announced; SEC exemption obtained for ADS holders
👉 Largest-ever buyback by Infosys, signalling confidence and strong cash flows.
2. Infosys Buyback History – Pattern of Capital Return
Year |
Size (₹ Cr) |
Route |
Price (₹) |
% of Equity |
Market Reaction (12M after) |
2017 |
~13,000 |
Tender |
~1,150 |
~4.9% |
Stock up ~25% |
2019 |
8,260 |
Tender |
800 |
~1.9% |
Modest gains |
2021 |
9,200 |
Tender |
1,750 |
~1.2% |
Stock flat/slight up |
2022–23 |
~9,300 (open market) |
Market purchase |
Avg ~1,650 |
~1.5% |
Neutral |
2025 |
18,000 |
Tender |
1,800 |
2.41% |
TBD |
📌 Takeaway: Infosys has established a buyback cycle every 2–3 years, usually around 1.5–3% of equity, offering shareholders periodic liquidity events.
3. Peer Comparison – Are Infosys Investors Better Off?
Company |
Latest Buyback |
Size (₹ Cr) |
Premium to CMP |
% of Equity |
TCS |
2022 |
18,000 |
~17% |
1.1% |
Wipro |
2023 |
12,000 |
~20% |
4.9% |
HCL Tech |
2022 |
4,000 |
~10% |
1.1% |
Infosys (2025) |
18,000 |
~19% |
2.41% |
|
👉 Infosys’ offer is competitive: higher % of equity than TCS/HCL, premium broadly in line with Wipro.
4. EPS & ROE Boost – Numbers That Matter
Impact:
5. Tax Angle – The Game Changer (Post Oct 1, 2024)
Old Regime (till Sep 2024):
New Regime (from Oct 2024):
-
Tax burden shifts to investors → treated as income (dividend).
-
TDS @ 10% for resident shareholders (adjustable at filing).
-
Final tax as per your slab.
📌 After-tax scenarios for ₹1,800/share buyback:
Investor |
Slab Rate |
Effective Net after Tax* |
Small retail |
10% |
~₹1,620 |
Mid bracket |
20% |
~₹1,440 |
High income |
30% |
~₹1,260 |
(*Approx, before surcharge/cess; assuming tender accepted in full.)
👉 High earners see net proceeds far below ₹1,800, reducing attractiveness.
6. Investor Archetypes – Who Should Tender?
-
Dividend-seeker / Short-term investor
-
Growth believer (long-term Infosys story)
-
✅ Hold: Benefit from higher EPS, stronger ROE, and long-term digital/AI growth.
-
❌ Miss immediate premium.
-
Tax-sensitive NRI / HNI
7. Why Not Just Dividends?
-
Dividends → recurring, signal long-term commitment.
-
Buybacks → flexible, one-off, offset ESOP dilution, EPS accretive.
-
Infosys already has a generous dividend policy; buybacks are used as an additional, discretionary tool.
8. Strategic Angle – Opportunity Cost
Analysts note ₹18,000 crore could alternatively go into:
-
Acquisitions (AI, cloud, cybersecurity)
-
R&D spend (Infosys Topaz, generative AI)
-
Talent retention in tight labour markets
👉 While buybacks support the stock, some argue investing in growth may yield higher long-term value.
9. Outlook Beyond Buyback
-
Short-term: Buyback offers floor support; tender route creates short-term trading interest.
-
Medium-term: EPS and ROE lift, but modest.
-
Long-term: Infosys’ fundamentals (deal pipeline, margin trajectory, digital transformation bets) matter far more than a 2.5% EPS bump.
🔑 Final Take – What’s in It for Investors?
-
Attractive on paper: 19% premium, largest-ever buyback, EPS accretive.
-
But tax erodes benefit: New rules shift burden to shareholders, making buybacks less lucrative for high-income brackets.
-
Strategic signal: Infosys is shareholder-friendly, confident in cash flows, but also conservative in capital allocation.
📌 For retail in lower tax brackets, tendering may still make sense. For long-term growth investors, holding could prove wiser, as Infosys’ value will ultimately track its ability to deliver digital and AI-led growth.
Discalimer!
The content provided in this blog article is for educational purposes only. The information presented here is based on the author's research, knowledge, and opinions at the time of writing. Readers are advised to use their discretion and judgment when applying the information from this article. The author and publisher do not assume any responsibility or liability for any consequences resulting from the use of the information provided herein. Additionally, images, content, and trademarks used in this article belong to their respective owners. No copyright infringement is intended on our part. If you believe that any material infringes upon your copyright, please contact us promptly for resolution.